The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2

Pancreatic adenocarcinoma (PDAC) is one of the most deadly cancers because of a lack of early diagnotic markers and efficient therapeutics. The fluorinated analog of deoxycytidine, gemcitabine and emerging FOLFIRINOX protocol (5-fluorouracil (5-FU), irinotecan/SN-38, oxaliplatin and leucovorin) are...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrypek, Nicolas, Vasseur, Romain, Vincent, Audrey, Duchêne, Bélinda, Van Seuningen, Isabelle, Jonckheere, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484424/
https://www.ncbi.nlm.nih.gov/pubmed/25890497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484424/
https://www.ncbi.nlm.nih.gov/pubmed/25890497

Ejemplares similares